Qure Ventures

CoreMap, Inc. develops a diagnostic technology for electrophysiologists for treating atrial fibrillation. It offers CoreMap micro-electrode solution for mapping tissue properties (ability to map sequentially). The company also provides CoreMap ultra-high resolution electrodes reveal the details of activation despite fibrillation. The company was incorporated in 2016 and is based in Winooski, Vermont.

Sweetch Health Ltd. is a company based in Jerusalem, Israel, focused on preventing chronic diseases such as diabetes, hypertension, hyperlipidemia, and obesity through its artificial intelligence-driven platform. Founded in 2013, Sweetch provides personalized recommendations tailored to individual behaviors, utilizing data from smartphones to gain insights into lifestyle habits. This technology predicts a person's three-year risk of developing metabolic syndrome-related diseases and implements interventions that emphasize emotional support and motivation to encourage long-term behavioral change. By offering scalable and cost-effective solutions, Sweetch aims to guide the prediabetic population toward healthier lifestyles and improve clinical outcomes for individuals managing chronic conditions, thus fostering continuous engagement with healthcare providers and other stakeholders.

Carevive Systems, Inc. is a healthcare technology company that specializes in developing a platform to enhance cancer care delivery and patient engagement. Based in North Miami, Florida, the company offers a range of tools including Carevive PROmpt, which facilitates treatment planning, symptom management, and survivorship care through a combination of electronic patient-reported outcomes (ePRO) and evidence-based care plans. Additionally, Carevive provides a Navigation/Care Coordination module that streamlines documentation and tracking of patient care plans, as well as a Risk Stratification model to identify at-risk patients. The platform integrates clinical data with patient-reported outcomes, enabling oncology practices to deliver personalized, dynamic care plans that improve clinical outcomes and support value-based care models. Carevive Systems was established in 2013 and previously operated under the name On Q Health, Inc. until its rebranding in 2015.

CoreMap, Inc. develops a diagnostic technology for electrophysiologists for treating atrial fibrillation. It offers CoreMap micro-electrode solution for mapping tissue properties (ability to map sequentially). The company also provides CoreMap ultra-high resolution electrodes reveal the details of activation despite fibrillation. The company was incorporated in 2016 and is based in Winooski, Vermont.

CyberMDX Technologies Inc. specializes in medical cybersecurity, focusing on the protection and management of connected healthcare devices and clinical assets. Founded in 2016 and based in New York, the company offers a comprehensive cybersecurity solution that enhances visibility, operational insights, and threat prevention for medical devices. Its platform includes features such as real-time asset discovery, micro-segmentation for isolating threats, and agentless asset identification. Additionally, CyberMDX provides inventory management, vulnerability research, AI-enabled network traffic monitoring, and operational analytics. By automating network hygiene and architecture, CyberMDX ensures the safety of patients and the continuity of hospital operations while enabling clients to effectively manage their Internet of Things (IoT) deployments in healthcare settings.

Sweetch Health Ltd. is a company based in Jerusalem, Israel, focused on preventing chronic diseases such as diabetes, hypertension, hyperlipidemia, and obesity through its artificial intelligence-driven platform. Founded in 2013, Sweetch provides personalized recommendations tailored to individual behaviors, utilizing data from smartphones to gain insights into lifestyle habits. This technology predicts a person's three-year risk of developing metabolic syndrome-related diseases and implements interventions that emphasize emotional support and motivation to encourage long-term behavioral change. By offering scalable and cost-effective solutions, Sweetch aims to guide the prediabetic population toward healthier lifestyles and improve clinical outcomes for individuals managing chronic conditions, thus fostering continuous engagement with healthcare providers and other stakeholders.

CyberMDX Technologies Inc. specializes in medical cybersecurity, focusing on the protection and management of connected healthcare devices and clinical assets. Founded in 2016 and based in New York, the company offers a comprehensive cybersecurity solution that enhances visibility, operational insights, and threat prevention for medical devices. Its platform includes features such as real-time asset discovery, micro-segmentation for isolating threats, and agentless asset identification. Additionally, CyberMDX provides inventory management, vulnerability research, AI-enabled network traffic monitoring, and operational analytics. By automating network hygiene and architecture, CyberMDX ensures the safety of patients and the continuity of hospital operations while enabling clients to effectively manage their Internet of Things (IoT) deployments in healthcare settings.

BrainQ Technolgies Ltd, a clinical-stage medtech company, develops brain-machine induction technologies to provide personalized, safe, and noninvasive treatments for neuro-disorders including stroke, traumatic brain injury, and spinal cord injury. It offers a cloud-based medical device that utilizes artificial intelligence to analyze patients’ EEG sensor data. The company was founded in 2011 and is based in Jerusalem, Israel.